---
$id: https://graph.org.ai/products/commodity/51111625
$type: Product
source: UNSPSC
code: "51111625"
title: "Azacitidine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Azacitidine

**UNSPSC Code**: 51111625
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist with the molecular formula C8H12N4O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M801H13NRU, chemically known as 1,3,5-triazin-2 (1h)-one, 4-amino-1-.beta.-d-ribofuranosyl- but generally known as azacitidine, which bears US NIH Compound Identifier 1805. European Medicines Agency schedules Azacitidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05624MIG. The term AZACITIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). World Health Organization schedules azacitidine in its Anatomical Therapeutic Chemical (ATC) Classification. AZACITIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule azacitidine under HS 29349990 and SITC 51579. As of Q4 2014, AZACITIDINE remains the US FDA Preferred Term for this commodity. Azacitidine bears US NLM identifiers UMLS ID C0004475 and NCI Concept Code C288. SMILES: O1C(C(O)C(O)C1N1C(=O)NC(NC1)N)CO.

